CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
Open Access
- 3 April 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 35 (6), 561-568
- https://doi.org/10.1038/nbt.3853
Abstract
Regulatory elements for specific human genes are rapidly identified with CRISPR epigenome editing. Large genome-mapping consortia and thousands of genome-wide association studies have identified non-protein-coding elements in the genome as having a central role in various biological processes. However, decoding the functions of the millions of putative regulatory elements discovered in these studies remains challenging. CRISPR–Cas9-based epigenome editing technologies have enabled precise perturbation of the activity of specific regulatory elements. Here we describe CRISPR–Cas9-based epigenomic regulatory element screening (CERES) for improved high-throughput screening of regulatory element activity in the native genomic context. Using dCas9KRAB repressor and dCas9p300 activator constructs and lentiviral single guide RNA libraries to target DNase I hypersensitive sites surrounding a gene of interest, we carried out both loss- and gain-of-function screens to identify regulatory elements for the β-globin and HER2 loci in human cells. CERES readily identified known and previously unidentified regulatory elements, some of which were dependent on cell type or direction of perturbation. This technology allows the high-throughput functional annotation of putative regulatory elements in their native chromosomal context.Keywords
This publication has 55 references indexed in Scilit:
- Loss-of-function genetic tools for animal models: cross-species and cross-platform differencesNature Reviews Genetics, 2016
- CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoterOncotarget, 2016
- Functional footprinting of regulatory DNANature Methods, 2015
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineeringNature Biotechnology, 2013
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonucleaseNature Biotechnology, 2013
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapiesExpert Review of Anticancer Therapy, 2011
- The NIH Roadmap Epigenomics Mapping ConsortiumNature Biotechnology, 2010
- Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifenNature, 2008
- Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarraysNature Methods, 2006